Tsumura & Co. (TYO:4540)

Japan flag Japan · Delayed Price · Currency is JPY
4,290.00
-114.00 (-2.59%)
Apr 24, 2025, 3:30 PM JST
13.07%
Market Cap 325.80B
Revenue (ttm) 171.79B
Net Income (ttm) 27.12B
Shares Out 75.94M
EPS (ttm) 357.20
PE Ratio 12.01
Forward PE 10.33
Dividend 136.00 (3.09%)
Ex-Dividend Date Mar 28, 2025
Volume 225,200
Average Volume 245,315
Open 4,404.00
Previous Close 4,404.00
Day's Range 4,276.00 - 4,413.00
52-Week Range 3,316.00 - 5,138.00
Beta 0.07
RSI 57.20
Earnings Date May 12, 2025

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, an... [Read more]

Sector Healthcare
Founded 1893
Employees 4,138
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4540
Full Company Profile

Financial Performance

In 2023, Tsumura & Co.'s revenue was 150.85 billion, an increase of 7.71% compared to the previous year's 140.04 billion. Earnings were 16.71 billion, an increase of 1.37%.

Financial Statements

News

There is no news available yet.